In keeping with these findings, misexpression of Sox3 has previously been demonstrated to cause oncogenic transformation of embryonic fibroblasts [41] whereas microRNA-mediated suppression of Sox2 decreases the capacity of glioma cells to contribute to tumor growth [8]. The gene discussed is SOX3; the disease is central nervous system cancer.